A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. AJPHS [Internet]. 2022 Dec. 30 [cited 2025 Oct. 15];12(4):2729-38. Available from: https://ajphs.com/index.php/ajphs/article/view/163